Genomic Vision 

0
0
+€0.00+0% 00:00 오늘

통계

일일 최고가
-
일일 최저가
-
52주 최고가
-
52주 최저
-
거래량
-
평균 거래량
-
시가총액
0
PER
-
배당수익률
-
배당
-

경쟁사

이 목록은 최근 시장 이벤트를 기반으로 한 분석입니다. 투자 권고가 아닙니다.

정보

Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.
더 보기
CEO
Mr. Aaron Bensimon
직원
27
국가
프랑스
ISIN
FR0011799907
WKN
000A110TM

상장

댓글 0개

생각을 공유하기

자주 묻는 질문

Genomic Vision의 주식 심볼은 무엇인가요?▼
거래소에 따라 주식 심볼이 다를 수 있습니다. 예를 들어, Boerse Muenchen 거래소에서는 Genomic Vision 주식이 G09.MU 심볼로 거래됩니다.
Genomic Vision에는 직원이 몇 명 있나요?▼
2026년 11월 1일 기준으로 회사는 27명의 직원을 보유하고 있습니다.
Genomic Vision는 어떤 섹터에 속해 있나요?▼
Genomic Vision는 헬스 & 웰니스 부문에서 운영됩니다.
Genomic Vision는 언제 주식 분할을 완료했나요?▼
Genomic Vision는 최근에 주식 분할을 하지 않았습니다.
Genomic Vision의 본사는 어디에 있나요?▼
Genomic Vision의 본사는 프랑스 Bagneux에 있습니다.